Dova Pharmaceuticals, Inc. (DOVA)
(Delayed Data from NSDQ)
$9.62 USD
+0.18 (1.91%)
Updated May 3, 2019 04:00 PM ET
After-Market: $9.64 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
[DOVA]
Reports for Purchase
Showing records 1 - 20 ( 32 total )
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Biotechnology - Down But Not Out: Looking Ahead to 3Q19 Biotech Reporting
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Downgrade to Neutral, Raising Price Target to $29 Following Acquisition Bid
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Industry: Medical - Drugs
No One Like You: Sobi to Acquire DOVA for Up to $29/Share
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Industry: Medical - Drugs
Happy Monday; SOBI to Take out Dova; Downgrade to Neutral, $27.50 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Industry: Medical - Drugs
Biotechnology - Hematology KOL Dinner Offers In-Depth Look Across ITP, PNH Landscapes
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Time to Start Paying Attention to Next Phase 3 Data Readout
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Industry: Medical - Drugs
Biotechnology - Overcoming Challenges in CNS Drug Development
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Industry: Medical - Drugs
Conference Takeaways: Encouraged By ITP Launch, CIT On Track
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Industry: Medical - Drugs
Industry: Medical - Drugs
2Q19 Results; Blocking and Tackling Continues; Eyes on ITP Launch; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Industry: Medical - Drugs
Industry: Medical - Drugs
On the Road Again... DOVA Management Travel Arrives at Opportune Time
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Industry: Medical - Drugs
Industry: Medical - Drugs
Biotechnology - Ahead of 2Q19 Biotech Reporting - Thoughts on Commercial Names
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Drugs
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Doptelet Starting to Get Interesting - ITP Approval, CIT Credit
Provider: WEDBUSH SECURITIES INC.